The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Corticosteroids for managing tuberculous meningitis
Open accessAbstract
BACKGROUND: Tuberculous meningitis is a serious form of tuberculosis (TB) that affects the meninges that cover a person's brain and spinal cord. It is associated with high death rates and with disability in people who survive. Corticosteroids have been used as an adjunct to antituberculous drugs to treat people with tuberculous meningitis, but their role has been controversial. OBJECTIVES: To evaluate the effects of corticosteroids as an adjunct to antituberculous treatment on death and severe disability in people with tuberculous meningitis. SEARCH METHODS: We searched the Cochrane Infectious Diseases Group Specialized Register up to the 18 March 2016; CENTRAL; MEDLINE; EMBASE; LILACS; and Current Controlled Trials. We also contacted researchers and organizations working in the field, and checked reference lists. SELECTION CRITERIA: Randomized controlled trials that compared corticosteroid plus antituberculous treatment with antituberculous treatment alone in people with clinically diagnosed tuberculous meningitis and included death or disability as outcome measures. DATA COLLECTION AND ANALYSIS: We independently assessed search results and methodological quality, and extracted data from the included trials. We analysed the data using risk ratios (RR) with 95% confidence intervals (CIs) and used a fixed-effect model. We performed an intention-to-treat analysis, where we included all participants randomized to treatment in the denominator. This analysis assumes that all participants who were lost to follow-up have good outcomes. We carried out a sensitivity analysis to explore the impact of the missing data. MAIN RESULTS: Nine trials that included 1337 participants (with 469 deaths) met the inclusion criteria.At follow-up from three to 18 months, steroids reduce deaths by almost one quarter (RR 0.75, 95% CI 0.65 to 0.87; nine trials, 1337 participants, high quality evidence). Disabling neurological deficit is not common in survivors, and steroids may have little or no effect on this outcome (RR 0.92, 95% CI 0.71 to 1.20; eight trials, 1314 participants, low quality evidence). There was no difference between groups in the incidence of adverse events, which included gastrointestinal bleeding, invasive bacterial infections, hyperglycaemia, and liver dysfunction.One trial followed up participants for five years. The effect on death was no longer apparent at this time-point (RR 0.93, 95% CI 0.78 to 1.12; one trial, 545 participants, moderate quality evidence); and there was no difference in disabling neurological deficit detected (RR 0.91, 95% CI 0.49 to 1.69; one trial, 545 participants, low quality evidence).One trial included human immunodeficiency virus (HIV)-positive people. The stratified analysis by HIV status in this trial showed no heterogeneity, with point estimates for death (RR 0.90, 95% CI 0.67 to 1.20; one trial, 98 participants) and disability (RR 1.23, 95% CI 0.08 to 19.07; one trial, 98 participants) similar to HIV-negative participants in the same trial. AUTHORS' CONCLUSIONS: Corticosteroids reduce mortality from tuberculous meningitis, at least in the short term.Corticosteroids may have no effect on the number of people who survive tuberculous meningitis with disabling neurological deficit, but this outcome is less common than death, and the CI for the relative effect includes possible harm. However, this small possible harm is unlikely to be quantitatively important when compared to the reduction in mortality.The number of HIV-positive people included in the review is small, so we are not sure if the benefits in terms of reduced mortality are preserved in this group of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global tuberculosis report (2014)
Gabbasova, L. A., & Who, E. R. E. (2014) · Cited by 12,702
Assessing the quality of controlled clinical trials
Jüni, P., Altman, D. G., & Egger, M. (2001) · BMJ · doi:10.1136/bmj.323.7303.42 · Cited by 3,309
Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults
Thwaites, G. E., Bang, N. D., Dung, N. H., Quy, H. T., Oanh, D. T. T., Thoa, N. T. C., Hien, N. Q., Thuc, N. T., Hai, N. N., Lan, N. T. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040573 · Cited by 1,043
Handbook of Clinical Neurology
Jellinger, K. A. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02422.x · Cited by 755
Dexamethasone for treatment of tuberculous meningitis in adolescents and adults
Tunkel, A. R. (2005) · Current Infectious Disease Reports · doi:10.1007/s11908-005-0059-0 · Cited by 671
Thwaites, G., Fisher, M., Hemingway, C., Scott, G., Solomon, T., & Innes, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.011 · Cited by 666
Newsom, S. W. B. (2006) · Journal of Hospital Infection · doi:10.1016/j.jhin.2006.06.003 · Cited by 635
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans
Tobin, D. M., Vary, J. C., Ray, J. P., Walsh, G. S., Dunstan, S. J., Bang, N. D., Hagge, D. A., Khadge, S., King, M.-C., Hawn, T. R., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.013 · Cited by 528
Tuberculous meningitis: more questions, still too few answers
Thwaites, G. E., van Toorn, R., & Schoeman, J. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70168-6 · Cited by 482
Extrapulmonary Tuberculosis in the United States
Rieder, H. L., Snider, D. E., & Cauthen, G. M. (1990) · American Review of Respiratory Disease · doi:10.1164/ajrccm/141.2.347 · Cited by 466
Tuberculous Meningitis in Patients Infected with the Human Immunodeficiency Virus
Berenguer, J., Moreno, S., Laguna, F., Vicente, T., Adrados, M., Ortega, A., González-LaHoz, J., & Bouza, E. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203053261004 · Cited by 432
Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features
Thwaites, G., Chau, T., Stepniewska, K., Phu, N., Chuong, L., Sinh, D., White, N., Parry, C., & Farrar, J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11318-3 · Cited by 395
Extrapulmonary Tuberculosis in Patients with Human Immunodeficiency Virus Infection
Shafer, R. W., Kim, D. S., Weiss, J. P., & Quale, J. M. (1991) · Medicine · doi:10.1097/00005792-199111000-00004 · Cited by 322
Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis
Heemskerk, A. D., Bang, N. D., Mai, N. T. H., Chau, T. T. H., Phu, N. H., Loc, P. P., Chau, N. V. V., Hien, T. T., Dung, N. H., Lan, N. T. N., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507062 · Cited by 310
Schoeman, J. F., Van Zyl, L. E., Laubscher, J. A., & Donald, P. R. (1997) · Pediatrics · doi:10.1542/peds.99.2.226 · Cited by 300
Dexamethasone adjunctive treatment for tuberculous meningitis
GIRGIS, N. I., FARID, Z., KILPATRICK, M. E., SULTAN, Y., & MIKHAIL, I. A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199103000-00002 · Cited by 217
Corticosteroids for managing tuberculous meningitis
Prasad, K., & Singh, M. B. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002244.pub3 · Cited by 207
Self-citationTreatment of Tuberculosis: (359142004-001)
US Department of Health & Human Services; Centers for Disease Control (CDC) (2003) · PsycEXTRA Dataset · doi:10.1037/e359142004-001 · Cited by 205
The Streptomycin Treatment of Tuberculous Meningitis
Cathie, I. A. B. (1948) · Postgraduate Medical Journal · doi:10.1136/pgmj.24.273.351 · Cited by 172
ENHANCING EFFECT OF CORTISONE ON TUBERCULOSIS IN THE MOUSE
Hart, P. D., & Rees, R. J. W. (1950) · The Lancet · doi:10.1016/s0140-6736(50)91344-4 · Cited by 151
Adjunctive Thalidomide Therapy for Childhood Tuberculous Meningitis: Results of a Randomized Study
Schoeman, J. F., Springer, P. E., van Rensburg, A. J., Swanevelder, S. A., Hanekom, W. A., Haslett, P. A. J., & Kaplan, G. (2004) · Journal of Child Neurology · doi:10.1177/088307380401900402 · Cited by 133
Dexamethasone in Tuberculous Meningitis
O'Toole, R. D., THORNTON, G. F., MUKHERJEE, M. K., & NATH, R. L. (1969) · Annals of Internal Medicine · doi:10.7326/0003-4819-70-1-39 · Cited by 124
Meta-Analysis: The Association Between HIV Infection and Extrapulmonary Tuberculosis
Naing, C. M., Mak, J. W., Maung, M., Wong, S. F., & Kassim, A. I. B. M. (2012) · Lung · doi:10.1007/s00408-012-9440-6 · Cited by 116
Mortality From Tuberculous Meningitis Reduced by Steroid Therapy
Escobar, J. A. D., Belsey, M. A., Duenas, A. P., & Medina, P. (1975) · PEDIATRICS · doi:10.1542/peds.56.6.1050 · Cited by 112
Simmons, C. P., Thwaites, G. E., Quyen, N. T. H., Chau, T. T. H., Phuong, P., Dung, N. T., Stepniewska, K., White, N. J., Hien, T. T., & Farrar, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.579 · Cited by 103
Dexamethasone and Long-Term Outcome of Tuberculous Meningitis in Vietnamese Adults and Adolescents
Török, M. E., Bang, N. D., Chau, T. T. H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027821 · Cited by 94
Steroids for treating tuberculous meningitis
Prasad, K., Volmink, J. A., & Menon, G. (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002244 · Cited by 86
Self-citationDonald, P. R., & Schoeman, J. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048227 · Cited by 86
STREPTOMYCIN treatment of tuberculous meningitis.
(1948) · PubMed · Cited by 84
Intensive short course chemotherapy for tuberculous meningitis
Jacobs, R. F., SUNAKORN, P., CHOTPITAYASUNONAH, T., Pope, S. K., & Kelleher, K. J. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199203000-00004 · Cited by 81
Dexamethasone and bacterial meningitis. A meta-analysis of randomized controlled trials.
Geiman, B. J., & Smith, A. L. (1992) · PubMed Central · Cited by 55
Schoeman, J. F., Andronikou, S., Stefan, D. C., Freeman, N., & van Toorn, R. (2010) · Journal of Child Neurology · doi:10.1177/0883073809350507 · Cited by 55
Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction
Molton, J. S., Huggan, P. J., & Archuleta, S. (2015) · The Medical Journal of Australia · doi:10.5694/mja14.00716 · Cited by 35
Jorge, J.-H., Cárdenas, G., Pablo, A.-P., & Soto‐Hernández, J. L. (2012) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318258b725 · Cited by 33
Lee, H., Lee, Y., Lee, S., Choi, S., Kim, Y. S., Woo, J. H., & Kim, S. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-011-0334-y · Cited by 26
Schoeman, J. F., Ravenscroft, A., & Hartzenberg, H. B. (2001) · Child s Nervous System · doi:10.1007/s003810000427 · Cited by 16
Steroids for treating tuberculous meningitis
Prasad, K., Volmink, J. A., & Menon, G. R. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002244.pub2 · Cited by 5
Self-citation
Cited by
Schneider, D. S., & Ayres, J. S. (2008) · Nature Reviews Immunology · doi:10.1038/nri2432 · Cited by 783
Thwaites, G., Fisher, M., Hemingway, C., Scott, G., Solomon, T., & Innes, J. (2009) · Journal of Infection · doi:10.1016/j.jinf.2009.06.011 · Cited by 666
Galgiani, J. N., Ampel, N. M., Blair, J. E., Catanzaro, A., Geertsma, F., Hoover, S. E., Johnson, R. H., Kusne, S., Lisse, J., MacDonald, J. D., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw360 · Cited by 622
Dheda, K., Barry, C. E., & Maartens, G. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00151-8 · Cited by 599
Host Genotype-Specific Therapies Can Optimize the Inflammatory Response to Mycobacterial Infections
Tobin, D. M., Roca, F. J., Oh, S. F., McFarland, R., Vickery, T. W., Ray, J. P., Ko, D. C., Zou, Y., Bang, N. D., Chau, T. T. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.12.023 · Cited by 580
Metadata
- Authors
- Prasad, K., Singh, M. B., & Ryan, H.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2016-04-28
- Volume
- 2016
- Issue
- 4
- Pages
- CD002244-CD002244
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2160408047
- Cited by
- 534
- References
- 38
- FWCI
- 50.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.